highly significantp = 0.000006
Chemerin, in particular, demonstrated a progressive increase from the control group to SOP, with a highly significant trend ( p = 0.000006), suggesting a dose–response relationship with SOP severity.
Chemerin, in particular, demonstrated a progressive increase from the control group to SOP, with a highly significant trend ( p = 0.000006), suggesting a dose–response relationship with SOP severity.
Fasting glucose, TG, and TC levels were elevated across the groups ( p < 0.01), with a significant trend even after adjustment for age, but not after the correction of multiple testing.